Protect Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '18 Jun 30, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Selling, General & Admin	0	0.12	0.04	0.03	0.03	0.02
Operating Expenses	0	0.12	0.04	0.03	0.03	0.02
Operating Income	-0	-0.12	-0.04	-0.03	-0.03	-0.02
Interest Expense	-0.01	-0.01	-	-	-	-
EBT Excluding Unusual Items	-0.02	-0.12	-0.04	-0.03	-0.03	-0.02
Other Unusual Items	-	-	-	-0.61	0.49	-
Pretax Income	-0.02	-0.12	-0.04	-0.64	0.46	-0.02
Net Income	-0.02	-0.12	-0.04	-0.64	0.46	-0.02
Net Income to Common	-0.02	-0.12	-0.04	-0.64	0.46	-0.02
Shares Outstanding (Basic)	1	1	1	0	0	0
Shares Outstanding (Diluted)	1	1	1	0	0	0
Shares Change (YoY)	-	-	151.36%	718.12%	21.25%	-
EPS (Basic)	-0.01	-0.11	-0.04	-1.44	8.48	-0.54
EPS (Diluted)	-0.02	-0.11	-0.04	-1.44	8.48	-0.54
EBIT	-0	-0.12	-0.04	-0.03	-0.03	-0.02

Updated Mar 6, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.